Poster Session 1
Category: Digital Health Technologies (DHT)
Poster Session 1
Avish Arora, MD, PhD
Fellow
Montefiore/Albert Einstein College of Med.
New York, New York, United States
Pe'er Dar, MD
Professor and Director, Division of Fetal Medicine
Montefiore Medical Center
Bronx, New York, United States
Georgios Doulaveris, MD
Maternal Fetal Medicine Attending
Montefiore Medical Center/Albert Einstein College of Medicine
Montefiore Medical Center/Albert Einstein College of Medicine, New York, United States
To quantify early patient engagement with an agentic AI virtual assistant for GDM.
Study Design:
Gestational diabetes mellitus (GDM) demands daily glucose checks, dietary adjustment, and timely nutritional guidance, but adherence often declines and educator capacity may not meet demand. We developed a patient-facing, agentic AI tool for GDM that received FDA approval as an investigational device to support self-management. The WhatsApp-based AI assistant coordinates six specialized agents (Glucose Logging, Glucose Analysis, Nutritional Advice, Daily Check-in, Vision, Physician Handoff). Functions include structured capture of patient-entered values, trend-based meal guidance, symptom triage, and automated physician handoffs. A secure dashboard allows clinicians to review real-time logs and AI-flagged alerts at-a-glance. Daily operations include a 09:00 am glucose summary and a supportive nudge after 22 h of disengagement (quiet hour rules enforced). Ten pregnant individuals with diet-controlled GDM enrolled 1 June–30 July 2025. Engagement metrics were extracted from every patient message; glucose targets were < 90 mg/dL fasting and < 120 mg/dL post meal.
Results:
Over 60 days, the assistant exchanged 2,170 total messages; 710 (33 %) originated from patients. Participants texted the coach on a median 17 separate days (range 1–59) and sent a median 3 messages per engaged day. At least one glucose value was logged on a median 24 days per patient, and 67% of those days contained ≥ 2 readings. Across 411 captured values, 71% met pregnancy targets. Two symptom texts (“nauseous”, “dizzy”) triggered clinician callbacks within 15 min; no hypoglycemia alerts were missed and no manual overrides were required.
Conclusion:
The agentic AI GDM Assistant sustained meaningful patient interaction and regular glucose logging during the critical first two months after GDM diagnosis, while safely triaging symptoms without added clinician workload. A randomized controlled trial comparing traditional nutritional counseling with agentic AI–based diabetes management is underway.